Company
ANGLE plc
Headquarters: Guildford, United Kingdom
Employees: 102
CEO: Mr. Andrew David William Newland
Market Cap
£39.6 Million
GBP as of Jan. 1, 2025
US$49.6 Million
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $219.88 B |
| Danaher | $177.43 B |
| Siemens Healthineers AG | $59.19 B |
| Agilent Technologies, Inc. | $43.57 B |
| Lonza Group Ltd | $41.66 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application. It also offers specialist circulating tumor cell enrichment and analysis services to support translational research studies and pharmaceutical trials. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | June 30, 2023 |
| Revenue TTM | £1.8 M |
| EBITDA | £-23,889,000 |
| Gross Profit TTM | £613,000 |
| Profit Margin | 58.89% |
| Operating Margin | -889.13% |
| Quarterly Revenue Growth | 185.40% |
Stocks & Indices
ANGLE plc has the following listings and related stock indices.
Stock: LSE: AGL wb_incandescent
Stock: FSX: DWV wb_incandescent
Stock: OTC: ANPCF wb_incandescent
Stock: OTC: ANPCY wb_incandescent